Pregnyl Market Report 2026

Pregnyl Market Overview

• The Pregnyl market growth in the historic period has been driven by growing use of hcg in fertility protocols, expansion of ivf and art clinics • Market expansion is supported by rising infertility prevalence, increasing demand for assisted reproduction • Growth Driver: Expansion Of Healthcare Infrastructure Drives Market Growth • Market Trend: Strategic Acquisitions Strengthen Fertility Drug Manufacturing Capabilities • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pregnyl Market?

Pregnyl is a medication containing the hormone human chorionic gonadotropin (hCG), which is used in various medical treatments. It is prescribed to stimulate ovulation in women undergoing fertility treatments, to improve male fertility by boosting testosterone and sperm production, and to treat undescended testicles in boys. It is administered via injection and should be used under medical supervision. The main indications for pregnyl are fertility treatments in women, male infertility, and hypogonadotropic hypogonadism. Fertility treatments using pregnyl for women are primarily aimed at stimulating ovulation in women have difficulty conceiving due to conditions such as polycystic ovary syndrome (PCOS) or other ovulatory disorders. Pregnyl contains human chorionic gonadotropin (hCG), which mimics the natural hormone that triggers ovulation. It is distributed through various channels such as hospitals pharmacies, retail pharmacies, and online pharmacies and is utilized by fertility clinics, research institutions and others.

What Is The Pregnyl Market Growth Forecast?

The growth in the forecast period can be attributed to rising infertility prevalence, increasing demand for assisted reproduction, expansion of fertility treatment access, growing male fertility awareness, increasing adoption of personalized hormone regimens. Major trends in the forecast period include increasing demand for fertility hormone therapies, rising use in assisted reproductive techniques, growing focus on male fertility treatments, expansion of injectable hormone applications, enhanced emphasis on controlled hormone administration.

Global Pregnyl Market Segmentation

1) By Indication: Fertility Treatments In Women, Male Infertility, Hypogonadotropic Hypogonadism 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 3) By End-User: Fertility Clinics, Research Institutions, Other End-Users

What Are The Drivers Of The Pregnyl Market?

The expansion of healthcare infrastructure is expected to propel the growth of the pregnyl market going forward. Healthcare infrastructure refers to the physical and organizational structures, facilities, resources, and systems that are necessary for delivering healthcare services to a population. The expansion of healthcare infrastructure is driven by several key factors, including the aging global population, the increase in chronic diseases, and technological advancements. Robust healthcare infrastructure supports pregnyl's growth by ensuring access to fertility treatments, proper storage, administration facilities, and trained healthcare professionals. For instance, in January 2024, according to the American Hospital Association, a US-based professional organizations company, in 2024, the United States has 6,120 hospitals with a total of 916,752 staffed beds and 33,679,935 total admissions across all facilities. Furthermore, in May 2024, according to a report published by the Office for National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Therefore, the expansion of healthcare infrastructure is driving the growth of the pregnyl industry. Increasing infertility rates are expected to propel the growth of the Pregnyl market going forward. Infertility refers to the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse. Infertility is rising because more couples delay childbearing into their late 30s, when fertility naturally declines. Pregnyl helps address infertility by supporting assisted reproductive techniques through its role in triggering ovulation or supporting the luteal phase. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization operating as a specialized agency of the United Nations, approximately 17.5% of the adult population, roughly 1 in 6 people globally, experience infertility in their lifetime, upending assumptions about regional disparities. Therefore, increasing infertility rates are expected to drive the growth of the Pregnyl industry.

Key Players In The Global Pregnyl Market

Major companies operating in the pregnyl market are Merck & Co.Inc.

Global Pregnyl Market Trends and Insights

In July 2025, Organon & Co., a U.S.-based pharmaceutical company, acquired Merck & Co., Inc.'s biotech manufacturing site at De Geer in Oss for an undisclosed amount. With this acquisition, Organon aimed to strengthen its fertility drug manufacturing capabilities and secure a supply of active ingredients for its fertility portfolio, including hCG-based products such as Pregnyl. Merck & Co., Inc. is a Germany-based pharmaceutical company specializing in innovative medicines, vaccines, and healthcare solutions across major therapeutic areas.

Regional Insights

North America was the largest region in the pregnyl market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Pregnyl Market?

The pregnyl market consists of sales of pregnyl injections, hCG-based injections, and specialized hCG vials. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pregnyl Market Report 2026?

The pregnyl market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pregnyl industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.